Contributions from donors like you have helped us advance life-enhancing research in cancer, chronic respiratory and metabolic conditions, infectious and rare diseases, and more. Friends like you enable our researchers to conduct hundreds of studies and clinical trials, acquire state-of-the-art equipment, and discover breakthrough treatments for the world’s most pressing healthcare challenges.
$8.75M
raised in FY24
21
donors made a gift > $100K
62
donors reengaged in FY24
20
states and growing: TLI supporters all over the U.S.
Letter from our CEO
I’ve spent my first six months as President and CEO of The Lundquist Institute listening to our faculty, staff, patients, and partners, and I’m more convinced than ever that The Lundquist Institute can set the standard for turning patient- and community-inspired ideas into real-world cures.
Your generosity is what makes that possible. With supporters like you, our research teams are already advancing new diagnostics, therapies, and preventive strategies that will touch lives far beyond our campus.
As we move forward, our focus is clear: accelerate discovery and delivery. Together, we will grow TLI into the nation’s leading biomedical research institution, identifying critical health breakthroughs and rapidly getting them to the people who need them most.
Thank you for joining us on this journey. I’m honored to have you as a partner in the impact we’re creating today—and for generations to come.
Joe W. Ramos, PhD
President and CEO
Recent Accomplishments
Explore stories that highlight how our research, supporters, and community are shaping the future of biomedical innovation and advances in human health.
Research
From Mixed to Matched: New Marker Pinpoints Therapeutically Relevant Stem Cell–Derived Islets
Human pluripotent stem cell–derived islets hold great promise as a functional cure for diabetes. But the absence of reliable markers to distinguish functionally competent islets has made their use in therapy somewhat of a gamble.
Transforming the Fight Against Deadly Fungal Infections: TLI Secures Over $11 Million in NIH Funding
TLI Investigator Dr. Ashraf S. Ibrahim has been awarded a multi-year grant totaling more than $11 million. This marks a major milestone in the global effort to combat mucormycosis, one of the world’s most lethal fungal infections.
Education
UCLA CTSI at The Lundquist Institute Hosts WINN CIPP Summer Program to Empower Future Clinical Researchers
The UCLA Clinical and Translational Science Institute (CTSI) at The Lundquist Institute is proud to once again serve as a host site for the Robert A. Winn Clinical Investigator Pathway Program (Winn CIPP).
Among TLI’s first high school summer fellows program cohort, Dr. de Virgilio now offers mentorship program of his own
“I already knew I wanted to be in medicine when I joined the High School Fellows Program all those years ago,” said Dr. de Virgilio. “But the program connected me with someone who had succeeded in academic medicine,” he added.
Community
Connecting Communities to Mental Health Care: A Look Back at the 2025 UCLA CTSI CERP Symposium
Over 100 mental health professionals and community members gathered the annual Community Engagement Research Program Symposium. This year’s topic offered a critical platform to address adolescent mental health and suicide prevention.
WIC, a federally funded program serving low-income women with children up to the age of five, offers healthy foods, breastfeeding support, nutrition education and referrals to other services.
Support TLI
Become part of our story. When you give to The Lundquist Institute, you’re not just supporting science, you’re helping write the next chapter of medical discovery. Your tax-deductible gift drives innovations that improve lives across the globe and ensures we remain at the forefront of research that changes the world.
